LOL!! Yes, I said that. To me, it doesn't matter too much what the analysts say, not even what management guides to. Demand will be the determinant. I think doctors will rejoice in discovering what this drug can do for their patients, just as I thought it was capable of doing for my wife, if it was better understood, and had regulatory approval, which it fully deserves.